Industry Leader Professor Fan Ruitai Dedicates Efforts to Our Hospital
National Chief Experts Providing Daily Consultations: Industry Leader Professor Fan Ruitai Dedicates Efforts to Our Hospital, Empowering a New Journey in Cancer Diagnosis and Treatment
On January 5, Professor Fan Ruitai, Standing Committee Member of the Tumor Radiotherapy Branch of the Chinese Medical Association and the 5th Chairman of the Radiotherapy Branch of the Henan Medical Association, joined the Lanzhou Heavy Ion Center of Gansu Wuwei Cancer Hospital in a routine residency model . This expert, who possesses both clinical practical experience and a vision for disciplinary development, provides core support for the high-quality development of the center's radiotherapy discipline and the leapfrog improvement of its clinical service levels, strongly demonstrating the hospital's new pattern of high-quality medical services characterized by "localized high-end medical resources and routine services from chief experts" .

As a Second-Grade Professor, Chief Physician, and doctoral supervisor, Professor Fan Ruitai's academic and clinical resume is outstanding. He is not only the academic leader for both the National Health Commission's Key Clinical Specialty in Oncology and Henan Province's Key Oncology Discipline but also guides technical direction at the national level as a Standing Committee Member of the Tumor Radiotherapy Committee of the Chinese Medical Association. From designing individualized radiotherapy plans to research on precise radiotherapy for common tumors like lung cancer and breast cancer, he understands both the diagnostic and therapeutic needs at the clinical frontline and the development logic of discipline construction . This "versatile advantage" enables him to precisely address the development needs of the Lanzhou Heavy Ion Center, serving as a "bridge" connecting advanced experience with local practice.
During ward rounds, Professor Fan works alongside the center's medical team: providing specialized guidance for complex cases, analyzing patient imaging data case by case, tracing the development of conditions, and dynamically adjusting treatment strategies together with the team. He not only focuses on ensuring the precision of heavy ion radiotherapy but also consistently reminds the team to consider patient treatment tolerance . Through this "hands-on" mentoring approach, he enhances the diagnostic and therapeutic capabilities of the center's team simultaneously, allowing every cancer patient to enjoy high-quality medical services on par with international standards.

In recent years, Gansu Wuwei Cancer Hospital has achieved significant results in promoting the heavy ion treatment alliance and the establishment of 50 expert workstations . As the only hospital globally operating two heavy ion treatment systems simultaneously, Gansu Wuwei Cancer Hospital is consistently committed to the continuous development and innovation of cancer treatment technologies . The Lanzhou Heavy Ion Center is the second heavy ion clinical application center operated by Gansu Wuwei Cancer Hospital utilizing China's proprietary heavy ion technology . This system commenced clinical operations at the Lanzhou Heavy Ion Center on November 15, 2024 . To date, the center has completed photon and heavy ion treatment for over 400 patients, covering diseases such as lung cancer, pancreatic cancer, liver cancer, and brain glioma.
Professor Fan Ruitai's current routine residency is another manifestation of the Lanzhou Heavy Ion Center's commitment to the philosophy of "Gathering Global Cutting-Edge Technologies to Universally Benefit Cancer Patients Worldwide" . The center not only actively introduces internationally leading heavy ion treatment technologies with an open and inclusive attitude, building bridges for transnational academic exchanges and engaging in deep technical dialogues and experience sharing with top experts from countries like Japan and Germany, but also, with a pragmatic and dedicated spirit, vigorously introduces domestic authoritative clinical expert resources . Through routine ward round guidance and personalized consultation services, it promotes the standardization of clinical practices and the homogenization of diagnostic and treatment levels, continuously deepening disciplinary connotation construction to light the lamp of life for cancer patients.

Professor Shen Wenjiang, Lifetime Honorary Professor of the Department of Radiation Oncology at Peking University Health Science Center

Professor Wang Junjie, President of the Lanzhou Heavy Ion Center of Gansu Provincial Wuwei Cancer Hospital and Chairman of the Oncology Radiotherapy Branch of the Chinese Medical Association

Professor Ma Lulin, Chief Physician and Professor in the Department of Urology at Peking University Third Hospital

Professor Xu Bo, Chief Physician in the Department of Radiation Oncology at Peking University Cancer Hospital

Professor Yasuo Yoshioka, renowned Japanese expert in brachytherapy and oncology from the Japanese Foundation for Cancer Research

Professor György Kovács, Honorary Retired Professor at the University of Lübeck (Germany) and Director of the Education Program at the Università Cattolica del Sacro Cuore (Italy)
In the future, the Lanzhou Heavy Ion Center of Gansu Wuwei Cancer Hospital will continue to build high-level academic exchange and expert collaboration platforms, attract top-tier medical resources from home and abroad, constantly enhance core diagnostic capabilities and service levels, allow advanced heavy ion treatment technology to benefit more cancer patients, and inject strong momentum into the construction of a healthy Northwest.